The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
The obesity drug developer Metsera said on Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of the weight-loss treatments Ozempic and Wegovy.
Pfiz... [1766 chars]